M. Aringer et al., PHOTOPHERESIS TREATMENT ENHANCES CD95 (FAS) EXPRESSION IN CIRCULATINGLYMPHOCYTES OF PATIENTS WITH SYSTEMIC-SCLEROSIS AND INDUCES APOPTOSIS, British journal of rheumatology, 36(12), 1997, pp. 1276-1282
We investigated the effects of photopheresis in systemic sclerosis by
analysing its influence on lymphocytes with regard to apoptosis and ex
pression of bcl-2 and fas. Peripheral blood lymphocytes isolated immed
iately before and 24 h after photopheresis were investigated for apopt
osis, bcl-2 and fas expression by fluorocytometry, and compared to con
trols. In addition, leucocytes from systemic sclerosis patients taken
directly from the photopheresis system were tested for apoptosis after
24 h in culture. fas expression was similar in controls and patients
with systemic sclerosis just before photopheresis, but increased 24 h
after photopheresis, mainly due to an increase of CD4(+)CD95(+) cells.
bcl-2 was overexpressed in scleroderma peripheral lymphocytes, but no
t influenced by photopheresis. As compared to healthy controls, the pe
rcentage of apoptotic cells 24 h after photopheresis was high in cultu
red lymphocytes, but not es vivo. The significant increase in fas on p
eripheral lymphocytes observed in this study may be a major operative
mechanism of photopheresis in addition to (and possibly related to) th
e induction of apoptosis.